Below are the most recent publications written about "Parathyroid Hormone" by people in Profiles.
-
Bishop CW, Ashfaq A, Choe J, Strugnell SA, Johnson LL, Norris KC, Sprague SM. Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial. Am J Nephrol. 2026; 57(1):109-119.
-
Ashfaq A, Choe J, Strugnell SA, Patel N, Sprague SM, Norris KC, Lerma E, Petkovich PM, Bishop CW, Ashfaq A. Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial. Am J Nephrol. 2025; 56(4):490-499.
-
Sinha SK, Sun L, Didero M, Martins D, Norris KC, Lee JE, Meng YX, Sung JH, Sayre M, Carpio MB, Nicholas SB. Vitamin D3 Repletion Improves Vascular Function, as Measured by Cardiorenal Biomarkers in a High-Risk African American Cohort. Nutrients. 2022 Aug 14; 14(16).
-
Laster M, Denburg M, Okuda Y, Kumar J, Furth S, Warady B, Kalantar-Zadeh K, Norris K, Salusky IB. Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease. J Bone Miner Res. 2021 02; 36(2):298-304.
-
Gasu V, Ashong M, Seferi A, Fitzpatrick A. Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review. JBI Database System Rev Implement Rep. 2019 Jan; 17(1):49-73.
-
Laster M, Soohoo M, Streja E, Elashoff R, Jernigan S, Langman CB, Norris KC, Salusky IB, Kalantar-Zadeh K. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis. Pediatr Nephrol. 2019 01; 34(1):107-115.
-
Norris KC, Edwina Barnett M, Meng YX, Martins D, Nicholas SB, Gibbons GH, Lee JE. Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D. Contemp Clin Trials. 2018 09; 72:20-25.
-
Gasu V, Ashong M, Seferi A, Fitzpatrick A. Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review protocol. JBI Database System Rev Implement Rep. 2018 Apr; 16(4):838-844.
-
Applewhite MK, White MG, Tseng J, Mohammed MK, Mercier F, Kaplan EL, Angelos P, Vokes T, Grogan RH. Normohormonal primary hyperparathyroidism is a distinct?form of primary hyperparathyroidism. Surgery. 2017 01; 161(1):62-69.
-
Torres A, Torregrosa V, Marcen R, Campistol JM, Arias M, Hern?ndez D, Fern?ndez C, Esforzado N, Paschoalin R, P?rez N, Garc?a AI, Del Amo M, Pom?s J, Gonz?lez Rinne A, Marrero D, P?rez E, Henr?quez F, D?az JM, Silva I, L?pez V, Perello M, Ramos D, Beneyto I, Cruzado JM, Mart?nez Castelao A, Bravo J, Rodr?guez M, D?az C, Crespo J, Anaya F, Rodr?guez ML, Cubero JJ, Pascual P, Romero R, Andr?s Belmonte A, Checa MD, Jim?nez C, Escuin F, Crespo M, Mir M, G?mez G, Bayes B, Gonz?lez MJ, Guti?rrez A, Cuberes M, Rodr?guez Benoit A, Garc?a T, Llamas F, Ortega A, Conde JL, G?mez Alamillo C. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study). Nefrologia. 2016 May-Jun; 36(3):255-67.